Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK's new drug application (NDA) for Blenrep ...

Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

Rhythm Technologies announced that it received approval in Japan for its Zio long-term continuous monitoring (LTCM) system.

The approval sets the stage for iRhythm to work towards a reimbursement decision for the system with the Japanese MHLW.

(RTTNews) - iRhythm Technologies, Inc. (IRTC), a digital health care company, Wednesday said it has received approval from the Japanese ...

Chugai seeks additional indication approval from Japan MHLW for Vabysmo to treat angioid streaks associated with neovascularization: Tokyo Monday, September 9, 2024, 12:00 Hrs [IS ...

JILPT, or the Japan Institute for Labour Policy and Training, is an incorporated administrative agency with the objective of the organization to contribute to the planning of labor policies and their ...

The Hemophagocytic Lymphohistiocytosis drugs in development market research report provides comprehensive information on the therapeutics under development for Hemophagocytic Lymphohistiocytosis, ...

The Hemorrhagic Shock drugs in development market research report provides comprehensive information on the therapeutics under development for Hemorrhagic Shock, complete with analysis by stage of ...

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved for GSK’s Nucala (mepolizumab) for the treatment of adults ...